Good news for patients treated with hormone deprivation therapy for their prostate cancer…..There is no increase risk in heart disease rate from this treatment.
This is an important finding and is documented in a 10-year follow-up study out of Sweden.
There has been concern that removing male hormone effects, might have a negative effect on heart disease risk, as manipulating hormone levels later in life, has been called into question in women, thus the aversion to starting hormone therapy ‘later’ in the menopause.
This information gives comfort to those who require this treatment approach for their advancing prostate cancer.
Still, keeping an eye on the heart, monitoring cholesterol, etc….is appropriate as it would be for any man over the age of 50, but no special considerations needs to be given.